[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100589737":3},{"organization":4,"armGroups":7,"interventions":10,"overallOfficials":12,"centralContacts":16,"locations":22,"responsibleParty":44,"collaborators":10,"id":46,"slug":10,"hasResults":47,"nctId":48,"briefTitle":49,"officialTitle":49,"acronym":10,"eligibilityCriteria":50,"healthyVolunteers":47,"sex":51,"minAge":52,"maxAge":10,"enrollmentInfo":53,"targetDuration":10,"studyType":56,"phases":10,"briefSummary":57,"conditions":58,"keywords":61,"overallStatus":25,"whyStopped":10,"lastUpdateSubmitDate":66,"lastUpdatePostDateStruct":67,"startDateStruct":70,"completionDateStruct":72,"leadSponsor":74,"locationsCount":75},{"fullName":5,"class":6},"Ain Shams University","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":10},"type 2 diabetic patients",null,"type 2 diabetes mellitus patients aged above 45 years old and tested for diabetic neuropathy",[13],{"name":14,"affiliation":5,"role":15},"Rana A Al Hilaly, MD","STUDY_DIRECTOR",[17],{"name":18,"role":19,"phone":20,"phoneExt":10,"email":21},"Wafaa M Mohamed Abd ElAzim, Masters degree","CONTACT","+201012932752","wafaa.mahmoud@med.asu.edu.eg",[23,40],{"facility":24,"status":25,"city":26,"state":27,"zip":28,"country":29,"cosmosGeoPoint":30,"geoPoint":35,"contacts":36},"Ain Shams university","RECRUITING","Cairo","Abbassia","00202","Egypt",{"type":31,"coordinates":32},"Point",[33,34],31.24967,30.06263,{"lat":34,"lon":33},[37],{"name":38,"role":19,"phone":20,"phoneExt":10,"email":39},"Wafaa M Mohamed Abd ElAzim, Masters","wafaa.mahmoud.@med.asu.edu.eg",{"facility":24,"status":25,"city":26,"state":27,"zip":28,"country":29,"cosmosGeoPoint":41,"geoPoint":43,"contacts":10},{"type":31,"coordinates":42},[33,34],{"lat":34,"lon":33},{"type":45,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR","100589737",false,"NCT06958302","The Relation Between Diabetic Neuropathy and Muscle Mass in Type 2 Diabetes Mellitus Patients","Inclusion Criteria:\n\n* The study group consisted of patients diagnosed with Type 2 diabetes mellitus aged ≥45 years old\n\nExclusion Criteria:\n\n* Type 1 DM, gestational diabetes mellitus\n* Severe cardiopulmonary disease, significant\u002Fprevious neurological disorder (e.g., ischemic stroke, Parkinson disease) causing difficulty during daily activities (e.g., walking), visual deficit, and psychiatric problem\n* Other neuropathy-associated factors such as: alcohol, nutrition, poisoning and drug addiction\n* Patients with renal diseases, malignancy and autoimmune diseases\n* Patients on long term use of Steroids","ALL","45 Years",{"count":54,"type":55},60,"ESTIMATED","OBSERVATIONAL","The goal of this observational study is to evaluate the relation between diabetic neuropathy in type 2 diabetes mellitus patients and muscle mass",[59,60],"Diabetic Neuropathy","Sarcopenia",[62,63,64,65],"diabetic neuropathy","muscle mass","sarcopenia","nerve conduction studies","2025-04-26",{"date":68,"type":69},"2025-05-06","ACTUAL",{"date":71,"type":55},"2025-05-30",{"date":73,"type":55},"2026-06-15",{"name":5,"class":6},2]